BHI News Section Archives - Page 38 of 1201

News

July 8, 2024

Arlington’s Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions

ARLINGTON, Va.--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and…

Andy

Love0

News

July 8, 2024

Ascentage Pharma Received US$100 Million Option Payment from Takeda

ROCKVILLE, Md. and SUZHOU, China, July 3, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both…

Andy

Love0

News

July 8, 2024

Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics

HONG KONG and GERMANTOWN, Md. and SUZHOU, China, July 8, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; stock code:…

Andy

Love0

News

July 3, 2024

Maryland Awards $500K to Early Charm Ventures for Biomanufacturing Incubator at Harford County Facility

BEL AIR, Md., (July 1, 2024) – Maryland Department of Commerce has awarded $500K to Baltimore-based Early Charm to develop a…

Andy

Love0

News

July 2, 2024

Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from…

Andy

Love0

News

July 2, 2024

EDA: Biden-Harris Administration Announces Next Funding Round of $504 Million for 12 Tech Hubs Across America

WASHINGTON, DC — The Biden-Harris Administration, through the U.S. Department of Commerce’s Economic Development Administration (EDA), announced another funding round of…

Andy

Love0

News

July 2, 2024

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering…

Andy

Love0

News

July 2, 2024

Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology…

Andy

Love0

News

July 1, 2024

TJP: 2023 Crab Trap Finalist EyeControl creates revolutionary medical technology

EyeControl improves clinical outcomes, prevent cognitive decline, and enhance the patient and family experience.“We are honoured to be able to…

Andy

Love0

News

July 1, 2024

From Tunisia to Maryland: FluoInk’s Journey at the SelectUSA Investment Summit

Professor Ramzi Maalej, CTO and Founder of FluoInk, recently traveled from Tunisia to Maryland to attend the SelectUSA Investment Summit.…

Andy

Love0

BHI News Section

Arlington’s Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions

Ascentage Pharma Received US$100 Million Option Payment from Takeda

Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics

Maryland Awards $500K to Early Charm Ventures for Biomanufacturing Incubator at Harford County Facility

Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

EDA: Biden-Harris Administration Announces Next Funding Round of $504 Million for 12 Tech Hubs Across America

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

TJP: 2023 Crab Trap Finalist EyeControl creates revolutionary medical technology

From Tunisia to Maryland: FluoInk’s Journey at the SelectUSA Investment Summit

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search